Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LIFE | AZN | AMGN | GILD | VRTX |
| Company | Atyr Pharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.8600 | 94.81 | 332.10 | 122.34 | 469.13 |
| High | 1.9500 | 96.51 | 343.05 | 124.71 | 487.52 |
| Low | 1.8200 | 94.12 | 332.10 | 122.16 | 467.46 |
| Latest | 1.9000 | 95.16 | 341.64 | 124.35 | 484.15 |
| Change | +0.0500 | +0.20 | +11.47 | +2.99 | +15.77 |
| % Change | +2.70% | +0.21% | +3.47% | +2.46% | +3.37% |
| Volume | 269,400 | 6,583,663 | 3,538,358 | 6,138,535 | 1,712,187 |
| 20-Day Average Volume | 540,290 | 4,705,562 | 2,768,565 | 6,350,790 | 1,229,641 |
| Previous Close | 1.8500 | 94.96 | 330.17 | 121.36 | 468.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8177 | 91.74 | 326.46 | 122.29 | 455.36 |
| 20-Day Raw Stochastic | 58.70% | 77.61% | 94.37% | 67.85% | 90.03% |
| 20-Day Relative Strength | 56.18 | 64.12 | 60.07 | 52.90 | 66.63 |
| Weighted Alpha | -6.86 | +45.45 | +31.10 | +33.30 | +20.30 |
| Today's Opinion | 100% Buy | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Previous Opinion | 96% Buy | 100% Buy | 88% Buy | 40% Buy | 72% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.15% since 05/28/24 | +2.54% since 12/30/25 | +3.76% since 12/30/25 | +0.69% since 12/30/25 | +6.26% since 12/30/25 |
| Low | 1.6500 on 05/30/24 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 1.9500 on 06/04/24 | 96.47 on 01/07/26 | 342.76 on 01/07/26 | 124.63 on 01/07/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | +18.01% since 05/03/24 | +5.19% since 12/05/25 | +3.38% since 12/05/25 | +2.31% since 12/05/25 | +5.86% since 12/05/25 |
| Low | 1.5901 on 05/06/24 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 433.81 on 12/10/25 |
| High | 2.0900 on 05/21/24 | 96.47 on 01/07/26 | 342.76 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +6.15% since 03/04/24 | +10.47% since 10/07/25 | +15.40% since 10/07/25 | +6.20% since 10/07/25 | +17.52% since 10/07/25 |
| Low | 1.5400 on 05/02/24 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 402.58 on 10/13/25 |
| High | 2.1500 on 03/20/24 | 96.47 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +50.20% since 12/04/23 | +36.23% since 07/07/25 | +16.42% since 07/07/25 | +10.95% since 07/07/25 | +4.95% since 07/07/25 |
| Low | 1.1400 on 12/11/23 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 2.1500 on 03/20/24 | 96.47 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 131,121 | 283,999,936 | 176,427,920 | 150,866,688 | 114,713,968 |
| Shares Outstanding, K | 69,011 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 350,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -50,390,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 240,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -15,490,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.19 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 05/02/24 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/14/24 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.12 | 14.97 | 14.99 | 29.61 |